Jan 8 (Reuters) - Orchid Pharma Ltd:
* GETS EIR FROM U.S. FDA-POST MARKETING ADVERSE DRUG EXPERIENCE REPORTING INSPECTION
* EIR RECEIVED FOR CO'S TAMIL NADU FACILITY Source text - bit.ly/2CO7kdA Further company coverage:
 